Form 8-K - Current report:
SEC Accession No. 0000950170-25-087921
Filing Date
2025-06-18
Accepted
2025-06-18 16:30:30
Documents
10
Period of Report
2025-06-17
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K rapp-20250617.htm   iXBRL 8-K 69091
  Complete submission text file 0000950170-25-087921.txt   182694

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT rapp-20250617.xsd EX-101.SCH 26973
12 EXTRACTED XBRL INSTANCE DOCUMENT rapp-20250617_htm.xml XML 5115
Mailing Address 99 HIGH STREET SUITE 2100 BOSTON MA 02110
Business Address 99 HIGH STREET SUITE 2100 BOSTON MA 02110 857-321-8020
Rapport Therapeutics, Inc. (Filer) CIK: 0002012593 (see all company filings)

EIN.: 880724208 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-42121 | Film No.: 251057344
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)